Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  New England Journal of Medicine

• Publication date

  2016-05-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMoa1513614PMID 27149033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.

  2015cited by this paper
• Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]).

  2014cited by this paper
• EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

  2014cited by this paper
• EHRA / HRS / APHRS expert consensus on ventricular arrhythmias

  2014cited by this paper
• Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families: A Scientific Statement From the American Heart Association

  2012cited by this paper
• AHA Scientific Statement Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families A Scientific Statement From the American Heart Association

  2012cited by this paper
• Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study

  2010cited by this paper
• Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.

  2010cited by this paper
• Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial

  2010cited by this paper
• Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials.

  2009cited by this paper
• Prophylactic catheter ablation for the prevention of defibrillator therapy.

  2007cited by this paper
• Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators: The OPTIC Study: A Randomized TrialConnolly SJ, for the Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators (McMaster Univ,

  2007cited by this paper
• ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines

  2006cited by this paper
• A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial.

  2006cited by this paper
• Comparison of (cid:1) -Blockers, Amiodarone Plus (cid:1) -Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators The OPTIC Study: A Randomized Trial

  2005cited by this paper
• Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone: Eleven-Year Follow-Up of a Subset of Patients in the Canadian Implantable Defibrillator Study (CIDS)

  2004cited by this paper
• Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results

  2004cited by this paper
• Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

  2003cited by this paper
• Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

  2000cited by this paper
• Population pharmacokinetics of long‐term oral amiodarone therapy

  2000cited by this paper
• Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

  1999cited by this paper
• A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

  1997cited by this paper
• Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.

  1993cited by this paper

• Electromechanical computational modeling of heart failure provides extensive analysis of cardiac pathophysiological features

  2026cites this paper
• Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia

  2026cites this paper
• Outcomes comparison between catheter ablation of ventricular tachycardia in Chagas disease versus ischemic and dilated cardiomyopathy — a retrospective cohort study

  2026cites this paper
• Efficacy and safety of ventricular tachycardia ablation versus antiarrhythmics in ischemic cardiomyopathy: a network meta-analysis.

  2026cites this paper
• Predicting Survival in Ventricular Tachycardia Storm: The CHAMPS Risk Score and Implications for Ablation Timing.

  2026cites this paper
• Simulation of perimitral ablation lines utilizing photon-counting CT-based mapping of atrial wall thickness and epicardial adipose tissue.

  2026cites this paper
• Heterogeneity of outcomes reporting in catheter ablation trials for ventricular tachycardia: a systematic review

  2026influential citation
• Ventricular Tachycardia Ablation Outcomes in Patients With Previous Implantable Cardioverter-Defibrillator Insertion: A Multicenter Cohort Study.

  2026cites this paper
• Psychological trauma and health-related quality of life following ventricular tachycardia ablation.

  2026cites this paper
• Incremental benefits of catheter ablation in patients with structural heart disease undergoing implantable cardioverter-defibrillator therapy for ventricular arrhythmias: A PRISMA compliant systematic review and meta analysis

  2026cites this paper
• Short- to Mid-term Outcomes of Refractory Electrical Storm Patients listed for Urgent Heart Transplantation

  2026cites this paper
• Quelle est la place de l’ablation des arythmies ventriculaires pour prévenir la mort subite en 2026 ?

  2026cites this paper
• The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic Devices.

  2026cites this paper
• In previous MI with ventricular tachycardia (VT), catheter ablation reduced mortality or VT events more than antiarrhythmic drug therapy at 4 y

  2025cites this paper
• Long-term outcome after multiple VT ablations in NICM patients.

  2025cites this paper
• The VANISH2 Trial and Its Implications for Cardiac Anesthesiologists.

  2025cites this paper
• Long-term outcomes of ventricular tachycardia ablation in patients presenting with electrical storm

  2025cites this paper
• Arrhythmia substrate identification using wideband motion-corrected late gadolinium enhancement magnetic resonance imaging in a swine model of myocardial infarction with taped implantable cardioverter-defibrillators

  2025cites this paper
• VT Substrate mapping - What's been done and what needs to be done.

  2025cites this paper
• Mortality and Readmissions after Ventricular Tachycardia Ablation: An Analysis of Inpatient and Outpatient State Databases.

  2025cites this paper
• Is catheter ablation the first line treatment of ventricular tachycardia after myocardial infarction?

  2025cites this paper
• Endo‐Epicardial vs. Endocardial‐Only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy: The EPIC‐VT Trial Design

  2025cites this paper
• Management of ventricular tachycardia in patients with advanced heart failure.

  2025cites this paper
• Approach to Ventricular Arrhythmias in Heart Failure

  2025cites this paper
• Catheter Ablation Versus Medical Therapy as First‐Line Treatment for Ventricular Electrical Storm: A Systematic Review and Meta‐Analysis

  2025influential citation
• High-density vs point-by-point mapping in ventricular tachycardia ablation: A comparative analysis of substrate characterization.

  2025cites this paper
• Feasibility Study: Characterizing Acute Lesion Dimensions in Patients With and Without Devices Using Non-Contrast (Native T1-weighted) MRI After VT/PVC Radiofrequency Ablation.

  2025cites this paper
• The Year in Electrophysiology: Selected Highlights from 2024.

  2025cites this paper
• JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias

  2025cites this paper
• Catheter ablation versus medical therapy for ventricular tachycardia in patients with ischemic heart disease: A systematic review and meta-analysis of randomized controlled trials

  2025influential citation
• The New Ice Age in Electrophysiology: Ultra-Low-Temperature Cryoablation for Ventricular Tachycardia

  2025cites this paper
• Outcomes of catheter ablation for ventr tachycardia in structural heart disease: a meta-analysis and quality appraisal of trials

  2025influential citation
• Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with inherited cardiomyopathies.

  2025cites this paper
• Cardioprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Patients undergoing Ventricular Tachycardia (VT) Ablation: A Propensity-Matched Cohort Study

  2025cites this paper
• Der erste ICD(implantierbarer Kardioverter-Defibrillator)-Schock

  2025cites this paper
• Ventricular tachycardia ablation in ischaemic cardiomyopathy: who, when and how?

  2025cites this paper
• Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial.

  2025cites this paper
• Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC

  2025cites this paper
• Reducing diverse sources of noise in ventricular electrical signals using variational autoencoders

  2025cites this paper
• Pulsed Field Ablation in Patients With Cardiac Implantable Electric Devices: Vigilance Is Warranted

  2025cites this paper
• Cardioprotective effects of Sodium-Glucose cotransporter-2 inhibitors in patients undergoing ventricular tachycardia (VT) ablation: a propensity-matched cohort study.

  2025cites this paper
• Safety and Efficacy of Stereotactic Cardiac Radio-Ablation for Ventricular Tachycardia in Patients at High Risk of Mortality

  2025cites this paper
• Dose-Dependent Ventricular Lesion Formation Using a Novel Large-Area Pulsed Field Ablation Catheter: A Preclinical Feasibility Study.

  2025cites this paper
• Catheter Ablation for Ventricular Tachycardia - The Case for Earlier Intervention.

  2025cites this paper
• Safety of immediate catheter ablation of ventricular arrhythmias in patients admitted via the emergency department

  2025cites this paper
• High‐Power Short‐Duration Temperature‐Controlled Radiofrequency Ablation for the Treatment of Outflow Tract Ventricular Arrhythmias

  2025cites this paper
• Ventricular Tachycardia Ablation in Patients With Severely Decreased Left Ventricular Ejection Fraction

  2025cites this paper
• Catheter Ablation for Ventricular Tachycardia After Myocardial Infarction: An Updated Meta-Analysis of Randomized Controlled Trials.

  2025cites this paper
• Catheter Ablation for Ischemic Ventricular Tachycardia: More Effective Than Sotalol, Safer Than Amiodarone.

  2025cites this paper
• Syncope and Ventricular Tachycardia: Revisiting the Evidence Base

  2025cites this paper
• Long-Term Outcomes and Post-Ablation Medication De-Escalation After Catheter Ablation for Premature Ventricular Complexes: A Nationwide Cohort Study

  2025cites this paper
• Impact of ventricular tachycardia ablation in the setting of electrical storm based on patient risk profile

  2025cites this paper
• Comparison of contact force sensing and non-contact force sensing catheters in ischemic cardiomyopathy patients with high ventricular arrhythmia burden

  2025cites this paper
• Antithrombotic Management in Catheter Ablation for ventricular arrhythmias -Mini review.

  2025cites this paper
• Heart Digital Twins Predict Features of Invasive Reentrant Circuits and Ablation Lesions in Scar-Dependent Ventricular Tachycardia

  2025cites this paper
• Cardiac Stereotactic Body Radiation Therapy (SBRT) for Refractory Ventricular Tachycardia Using Innovative Motion Tracking With Electroanatomical Mapping and CyberKnife Synchrony

  2025cites this paper
• Pulsed field ablation for ventricular tachycardia: are we there yet?

  2025cites this paper
• Case report of ventricular tachycardia simulation facilitated ablation for refractory ventricular arrhythmia post-myocardial infarction: aiming before firing

  2025cites this paper
• Dexterous Intramyocardial Needle Ablation (d-INA): Design, Fabrication, and In-Vivo Validation

  2025cites this paper
• Breaking the Rhythm: Extracorporeal Membrane Oxygenation (ECMO) as a Life Saver in a Case of Resistant Arrhythmia and Cardiac Arrest

  2025cites this paper
• Safety of ventricular tachycardia ablation under deep sedation with propofol and fentanyl

  2025cites this paper
• Prolonged Hospitalization After Catheter Ablation of Ventricular Tachycardia: Predictors and Outcomes.

  2025cites this paper
• Characterization of the Thermal Properties of Healthy vs Infarcted Ventricular Tissue: Implications for Radiofrequency Ablation.

  2025cites this paper
• Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR)

  2025cites this paper
• Early catheter ablation versus conservative- only management in patients with electrical storm. Systematic review and meta- analysis.

  2025cites this paper
• Timing of Catheter Ablation for Ventricular Tachycardia and Prognosis After Emergent Hospitalization　― Results From the JROAD-DPC Database ―

  2025cites this paper
• A Comprehensive Review of a Mechanism-Based Ventricular Electrical Storm Management

  2025cites this paper
• Critique on “Impact of Catheter Ablation for Ventricular Tachycardia on Left Ventricular Ejection Fraction in Patients With Structural Heart Disease”

  2025cites this paper
• Catheter ablation for refractory ventricular tachycardia early after acute myocardial infarction: management, electrophysiological characteristics, and outcomes

  2025cites this paper
• Ryanodine Receptor Inhibition with Dantrolene Prevents Ventricular Tachycardia Induction in Patients with Structural Heart Disease: A Randomized Controlled Trial

  2025cites this paper
• The Postoperative S Wave in Lead V5 and/or V6 Predicts Better Clinical Outcomes in Heart Failure Patients With Left Bundle Branch Area Pacing

  2025cites this paper
• AI-Based QRS Onset Detection in the Early Ventricular Activation Site ECGs

  2025cites this paper
• Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: A Meta‐Analysis With Reconstructed Time‐to‐Event and Trial Sequential Analysis

  2025cites this paper
• Ventricular Tachycardia Substrate Mapping with Cardiac Computed Tomography and Cardiac Magnetic Resonance Imaging: Head-to-head Comparison of Two Clinically Available Post-processing Platforms.

  2025cites this paper
• Arrhythmogenic sites identification in post-ischemic ventricular tachycardia electrophysiological studies by explainable deep learning

  2025cites this paper
• Ventricular Tachycardia Cycle Length and Response to Rhythm Control Therapy: Insights From the VANISH Trial.

  2025cites this paper
• Early substrate-based catheter ablation vs. antiarrhythmic drug therapy for ventricular tachyarrhythmias among patients with prior myocardial infarction: the MANTRA-VT randomized trial

  2025cites this paper
• Prognostic Value of Antiarrhythmic Drug Suppression of Electrical Storm Prior to Ventricular Tachycardia Ablation

  2025cites this paper
• Assessment of Intraprocedural Automated Arrhythmia Origin Localization System for Localizing Pacing Sites in 3D Space.

  2025cites this paper
• Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

  2025cites this paper
• Catheter ablation vs. anti-arrhythmic drug therapy for ventricular tachycardia in ischaemic heart disease: a meta-analysis of randomized controlled trials

  2025cites this paper
• Machine Learning Localization of Early Right Ventricular Activation Sites Using QRS Integral Features.

  2025cites this paper
• Personalized Heart Digital Twins Detect Substrate Abnormalities in Scar-Dependent Ventricular Tachycardia

  2025cites this paper
• Outcomes in Catheter Ablation of Sustained Ventricular Tachycardia in Myocarditis Compared with Ischemic Heart Disease

  2025cites this paper
• Near‐Infrared Spectroscopic Mapping of the Human Epicardium

  2025cites this paper
• Stellenwert der Ablation ventrikulärer Tachykardien bei Patienten mit systolischer Herzinsuffizienz

  2025cites this paper
• Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy.

  2025cites this paper
• Targeting Ventricular Arrhythmias in Non-Ischemic Patients: Advances in Diagnosis and Treatment

  2025cites this paper
• JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias.

  2025cites this paper
• Out-of-Hospital Cardiac Arrest in Apparently Healthy, Young Adults.

  2025cites this paper
• Tempering the Storm of Arrhythmias in Adults With Congenital Heart Disease

  2024cites this paper
• Catheter Ablation of Ventricular Tachycardia in Ischemic Heart Disease: What Is Known and New Perspectives

  2024cites this paper
• Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC—endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society

  2024influential citation
• The point on the treatment of arrhythmic storm

  2024cites this paper
• Intramural needle ablation or repeated standard ablation in patients referred for repeat ablation of scar‐related ventricular tachycardia

  2024cites this paper
• Surgical ventricular reconstruction and intraoperative cryoablation in a patient with drug-refractory ventricular tachycardia and left ventricular thrombus: a case report

  2024cites this paper
• Mechanical Circulatory Support Systems in the Management of Ventricular Arrhythmias: A Contemporary Overview

  2024cites this paper
• Reducing Stroke Risk After Catheter Ablation of Ventricular Arrhythmias: Time to Standardize Postprocedural Regimen?

  2024cites this paper
• Comparisons of Long-Term Clinical Outcomes with Left Bundle Branch Pacing, Left Ventricular Septal Pacing and Biventricular Pacing for Cardiac Resynchronization Therapy.

  2024cites this paper
• Neuraxial Modulation for Refractory Ventricular Arrhythmias.

  2024cites this paper